BLUE BELL, Pa., Feb. 21, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO) announced today that David B. Weiner, Ph.D., Professor, Department of Pathology & Laboratory Medicine, University of Pennsylvania, and Chairman of Inovio's Scientific Advisory Board, has been elected a fellow in the American Association for the Advancement of Science (AAAS). Dr. Weiner, often called the "father of synthetic DNA vaccines," is being honored for his pioneering and enabling discoveries in the area of synthetic DNA vaccines and promoting the nascent field of research during its early stages. Dr. Weiner was recognized at the Fellows Forum held February 18th during the AAAS Annual Meeting in Vancouver, Canada.
Dr. Weiner's laboratory helped to found the field of synthetic DNA vaccines in the early 1990s. His laboratory and collaborators were responsible for the first synthetic DNA vaccine Investigational New Drug application (IND). This IND for HIV immune therapy became the first IND approved as a synthetic DNA therapeutic vaccine. His studies were the first to establish that synthetic DNA vaccines appear well tolerated and are immunogenic in humans.
Dr. J. Joseph Kim, President and CEO, said, "This award is further recognition of David's visionary and untiring efforts at his lab in the University of Pennsylvania. These efforts led to the first discovery in the field of synthetic DNA vaccines. He created the scientific foundation for Inovio's clinical stage pipeline of synthetic vaccines for cancer, HIV, influenza and many other infectious diseases. It is through David's work that we may look back at this period and call it the "era of synthetic vaccines. We at Inovio congratulate David on this prestigious honor."
The AAAS Fellowship is based on scientifically or socially distinguished efforts to advance science or its applications. Members are elected to the organization by their peers. AAAS has been electing accomplished scientists to its society since 1874. The American Association for the Advancement of Science is an international non-profit organization dedicated to advancing science around the world by serving as an educator, leader, spokesperson and professional association. In addition to organizing membership activities, AAAS publishes the journal Science, as well as many scientific newsletters, books and reports, and spearheads programs that raise the bar of understanding for science worldwide.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV